Trial Profile
Comparative Randomized Trial of Rapamycin versus Paclitaxel-eluting stent in AMI.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Jul 2017
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Paclitaxel
- Indications Coronary artery disease; Coronary artery restenosis; Myocardial infarction
- Focus Therapeutic Use
- Acronyms CEZAR
- 16 Sep 2011 Actual end date (1 Dec 2006) added as reported by ISRCTN: Current Controlled Trials.
- 16 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 30 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by Netherlands Trial Register record.